NCT03369379View on ClinicalTrials.gov

Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS.

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2017

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
FibromyalgiaD Vitamin Deficiency
Interventions
DRUG

D3 Vitamin

Subjects will receive a capsule of 50,000 units of vitamin D3 echa week for 12 weeks, basal levels of vitamin D will be taken and again at week 12.

OTHER

Placebo

Placebo pill

Trial Locations (1)

66460

Universidad Autónoma de Nuevo León, Monterrey

All Listed Sponsors
lead

Universidad Autonoma de Nuevo Leon

OTHER

NCT03369379 - Valuation of Efficacy and Safety of Vitamin D3 Use in 80 Women Diagnosed With Fibromyalgia. Using FIQ Score and VAS. | Biotech Hunter | Biotech Hunter